Literature DB >> 15293949

Optimization of expression of an annexin V-hirudin chimeric protein in Escherichia coli.

Hui Yuan1, Xiang Yang, Zi-Chun Hua.   

Abstract

A human Annexin V-Hirudin chimeric protein, Annexin V-Hirudin C, was expressed in Escherichia coli. A broad range of parameters such as plasmid stability during propogation and expression, expression capacity stability, the culture media, the growth time before induction and the induction duration were examined and optimized. Recombinant Annexin V-Hirudin C was purified from the cell lysate supernatants by ethanol precipitation, DEAE-cellulose chromatography and Sephadex G-75 chromatography, and the purified protein showed dose-dependent thrombin inhibitory activity. The overall production of purified Annexin V-Hirudin C protein is 10 mg/l/OD600.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293949     DOI: 10.1016/j.micres.2004.02.002

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  7 in total

1.  An αIIbβ3- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis.

Authors:  Jian Jing; Yanna Sun
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

2.  Production and characterization of hirudin variant-1 by SUMO fusion technology in E. coli.

Authors:  Wuguang Lu; Xueting Cai; Zhenghua Gu; Yuzheng Huang; Binbin Xia; Peng Cao
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

3.  Robust preparative-scale extracellular production of hirudin in Escherichia coli and its purification and characterization.

Authors:  Cuicui Huang; Xuerui Zhang; Jia Qu; Ping Zhang; Shuhua Tan
Journal:  J Ind Microbiol Biotechnol       Date:  2012-07-31       Impact factor: 3.346

4.  Production of a new non-specific nuclease from Yersinia enterocolitica subsp. palearctica: optimization of induction conditions using response surface methodology.

Authors:  Xiu-Juan Fang; Zhen-Xing Tang; Zhen-Hua Li; Zhi-Liang Zhang; Lu-E Shi
Journal:  Biotechnol Biotechnol Equip       Date:  2014-08-26       Impact factor: 1.632

5.  Production of recombinant human annexin V by fed-batch cultivation.

Authors:  Laura S Marder; Juleane Lunardi; Gaby Renard; Diana C Rostirolla; Guilherme O Petersen; José E S Nunes; Ana Paula D de Souza; Ana Christina de O Dias; Jocelei M Chies; Luiz A Basso; Diógenes S Santos; Cristiano V Bizarro
Journal:  BMC Biotechnol       Date:  2014-04-27       Impact factor: 2.563

6.  Characterization of Annexin V Fusion with the Superfolder GFP in Liposomes Binding and Apoptosis Detection.

Authors:  Abdul Qader Abbady; Aya Twair; Bouthaina Ali; Hossam Murad
Journal:  Front Physiol       Date:  2017-05-19       Impact factor: 4.566

Review 7.  Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies.

Authors:  Li Li; Sainan Liu; Jianying Tan; Lai Wei; Dimeng Wu; Shuai Gao; Yajun Weng; Junying Chen
Journal:  J Tissue Eng       Date:  2022-03-24       Impact factor: 7.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.